ImmunoPhotonics

ImmunoPhotonics

ImmunoPhotonics

Developing a novel immunotherapy inCVAX, a minimally invasive vaccine that intends to cause a systemic antitumor response to treat late-stage metastatic cancers
Founded
2008
Raised
$1.8M
Follow us
Alexa global traffic share
Twitter followers
03 Sep 2014
$1,800,000
Venture capital (Series A)